Document:

Form of Change of Control and Severance Agreement for Vice Presidents

 Exhibit 10.23 
 THERMAGE, INC. 
 CHANGE OF CONTROL AND SEVERANCE AGREEMENT 
 This Change of Control Severance Agreement (the “Agreement”) is made and entered into by and between [NAME] (“Executive”) and
Thermage, Inc. (the “Company”), effective as of June 16, 2008 (the “Effective Date”). 
 RECITALS 

1. It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control.
The Compensation Committee (the “Committee”) of the Board of Directors of the Company (the “Board”) recognizes that such consideration can be a distraction to Executive and can cause Executive to consider alternative employment
opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or
occurrence of a Change of Control of the Company. 
 2. The Committee believes that it is in the best interests of the Company and its
stockholders to provide Executive with an incentive to continue his or her employment and to motivate Executive to maximize the value of the Company upon a Change of Control for the benefit of its stockholders. 
 3. The Committee believes that it is imperative to provide Executive with certain severance benefits upon Executive’s termination of employment
following a Change of Control. These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change of Control. 
 4. Certain capitalized terms used in the Agreement are defined in Section 5 below. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the mutual covenants contained
herein, the parties hereto agree as follows: 
 1. Term of Agreement. This Agreement will continue indefinitely until terminated by
written consent of the parties hereto. Notwithstanding the previous sentence, if Executive becomes entitled to benefits pursuant to Section 3 of this Agreement, the Agreement will terminate when all of the obligations of the parties hereto with
respect to this Agreement have been satisfied. 

 2. At-Will Employment. The Company and Executive acknowledge that Executive’s employment is
and will continue to be at-will, as defined under applicable law. If Executive’s employment terminates for any reason, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this
Agreement and the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses. 
 3. Severance
Benefits. 
 (a) Termination without Cause or Resignation for Good Reason Apart From a Change of Control. If the
Company terminates Executive’s employment with the Company without Cause or if Executive resigns from such employment for Good Reason, and such termination occurs either prior to three (3) months before or after twelve (12) months
following a Change of Control, and Executive signs and does not revoke a release of claims with the Company (in a form reasonably acceptable to the Company and substantially similar to the form attached hereto as Exhibit A and effective no later
than March 15 of the year following the year in which the termination occurs), then Executive will receive the following from the Company: 
 (i) Accrued Compensation. The Company will pay Executive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and
arrangements. 
 (ii) Severance Payment. Executive will receive a lump sum payment of severance equal to 50% of
Executive’s annual base salary as in effect immediately prior to Executive’s termination date. 
 (iii) Equity
Awards. Executive will not receive any accelerated vesting of his or her outstanding equity awards, except as may be set forth in Executive’s individual equity award agreements or the terms of the Company’s equity award plans.

 (iv) Continued Employee Benefits. If Executive elects continuation coverage pursuant to the Consolidated Omnibus
Budget Reconciliation Act of 1985, as amended (“COBRA”) for Executive and Executive’s eligible dependents, within the time period prescribed pursuant to COBRA, the Company will reimburse Executive for the COBRA premiums for such
coverage (at the coverage levels in effect immediately prior to Executive’s termination) until the earlier of (A) a period of six (6) months from the last date of employment of Executive with the Company, or (B) the date upon
which Executive and/or Executive’s eligible dependents becomes covered under similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company’s normal expense reimbursement policy. 
 (b) Termination without Cause or Resignation for Good Reason in Connection with a Change of Control. If the Company terminates
Executive’s employment with the Company without Cause or if Executive resigns from such employment for Good Reason, and such termination occurs within the period beginning three (3) months before and ending twelve (12) months after a
Change of Control, and Executive signs and does not revoke a release of claims with the Company (in a form reasonably acceptable to the Company and substantially similar to the form attached hereto as Exhibit A and effective no later than
March 15 of the year following the year in which the termination occurs), then Executive will receive the following from the Company: 
 (i) Accrued Compensation. The Company will pay Executive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and
arrangements. 
  

 -2- 

 (ii) Severance Payment. Executive will receive a lump sum payment of severance
equal to 50% of the sum of (x) Executive’s annual base salary as in effect immediately prior to Executive’s termination date or (if greater) at the level in effect immediately prior to the Change of Control and
(y) Executive’s annual target bonus for the fiscal year of Executive’s termination or (if greater) Executive’s annual target bonus in effect immediately prior to the Change of Control. 
 (iii) Equity Awards. Executive’s outstanding equity awards will vest in full as to 100% of the unvested portion of the award.

 (iv) Continued Employee Benefits. If Executive elects continuation coverage pursuant to COBRA for Executive and
Executive’s eligible dependents, within the time period prescribed pursuant to COBRA, the Company will reimburse Executive for the COBRA premiums for such coverage (at the coverage levels in effect immediately prior to Executive’s
termination) until the earlier of (A) a period of six (6) months from the last date of employment of Executive with the Company, or (B) the date upon which Executive and/or Executive’s eligible dependents becomes covered under
similar plans. COBRA reimbursements will be made by the Company to Executive consistent with the Company’s normal expense reimbursement policy. 
 (c) Timing of Severance Payments. Unless otherwise required by Section 3(g), the Company will pay any severance payments in a lump sum in a lump sum one (1) month after Executive’s termination
date; provided, however, that no severance or other benefits will be paid or provided until the release of claims discussed in Section 3(a) or 3(b) becomes effective, and any severance amounts or benefits otherwise payable between
Executive’s termination date and the date such release becomes effective will be paid on the effective date of such release. If Executive should die before all of the severance amounts have been paid, such unpaid amounts will be paid in a
lump-sum payment promptly following such event to Executive’s designated beneficiary, if living, or otherwise to the personal representative of Executive’s estate. 
 (d) Voluntary Resignation; Termination for Cause. If Executive’s employment with the Company terminates (i) voluntarily
by Executive (other than for Good Reason) or (ii) for Cause by the Company, then Executive will not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company’s then existing
severance and benefits plans and practices or pursuant to other written agreements with the Company. 
 (e) Disability;
Death. If the Company terminates Executive’s employment as a result of Executive’s Disability, or Executive’s employment terminates due to his or her death, then Executive will not be entitled to receive severance or other
benefits except for those (if any) as may then be established under the Company’s then existing written severance and benefits plans and practices or pursuant to other written agreements with the Company. 
  

 -3- 

 (f) Exclusive Remedy. In the event of a termination of Executive’s employment
as set forth in Section 3(a) or 3(b) of this Agreement, the provisions of Section 3(a) or 3(b), as applicable, are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise
be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses). Executive will be entitled to no benefits,
compensation or other payments or rights upon a termination of employment other than those benefits expressly set forth in Section 3 of this Agreement. 
 (g) Section 409A. 
 (i) Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A of the Internal Revenue Code of 1986, as amended (the
“Code”) and the final regulations and any guidance promulgated thereunder (“Section 409A”) at the time of Executive’s termination (other than due to death), then the severance payable to Executive, if any, pursuant to this
Agreement, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the “Deferred Compensation Separation Benefits”) that are payable
within the first six (6) months following Executive’s termination of employment, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s
termination of employment. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive
dies following his or her termination but prior to the six (6) month anniversary of his or her termination, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after
the date of Executive’s death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is
intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. 
 (ii) Any
amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations shall not constitute Deferred Compensation Separation Benefits for
purposes of clause (i) above. 
 (iii) Any amount paid under this Agreement that qualifies as a payment made as a result
of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that do not exceed the Section 409A Limit shall not constitute Deferred Compensation Separation Benefits for purposes of clause
(i) above. 
 (iv) The foregoing provisions are intended to comply with the requirements of Section 409A so that
none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together
in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under
Section 409A. 
  

 -4- 

 4. Limitation on Payments. In the event that the severance and other benefits provided for in this
Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code, and (ii) but for this Section 4, would be subject to the excise tax imposed by
Section 4999 of the Code, then the severance benefits under Section 3 will be either: 
 (a) delivered in full, or

 (b) delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under
Section 4999 of the Code, 
 whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise
tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. Unless the
Company and Executive otherwise agree in writing, any determination required under this Section 4 will be made in writing by the Company’s independent public accountants immediately prior to a Change of Control or such other person or
entity to which the parties mutually agree (the “Accountants”), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 4,
the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will
furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 4. The Company will bear all costs the Accountants may incur in connection with any
calculations contemplated by this Section 4. 
 5. Definition of Terms. The following terms referred to in this Agreement will
have the following meanings: 
 (a) Cause. “Cause” will mean: 
 (i) Executive’s willful failure to substantially perform Executive’s duties hereunder, other than a failure resulting from
Executive’s complete or partial incapacity due to physical or mental illness or impairment; 
 (ii) Executive’s
willful act which constitutes gross misconduct and which is injurious to the Company; 
 (iii) Executive’s willful breach
of a material provision of this Agreement; or 
 (iv) Executive’s knowing, material and willful violation of a federal or
state law or regulation applicable to the business of the Company. 
  

 -5- 

 In the event of any alleged breach pursuant to (i) or (iii) of this
Section 5(a), the Company will first give Executive written notice of the conduct constituting the alleged performance breach and provide Executive with sufficient information to enable Executive to correct the deficiency within a reasonable
time period, which will not be less than thirty (30) days, before the Company can proceed with a termination for Cause under either (i) or (iii) of this Section 5(a). 
 (b) Change of Control. “Change of Control” will mean the occurrence of any of the following events: 
 (i) Change in Ownership of the Company. A change in the ownership of the Company which occurs on the date that any one person, or
more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company, except
that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board will not be considered a Change of Control; or 
 (ii) Change in Effective Control of the Company. A change in the effective control of the Company which occurs on the date that a
majority of members of the Board is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes
of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change of Control; or 
 (iii) Change in Ownership of a Substantial Portion of the Company’s Assets. A change in the ownership of a substantial portion
of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a
total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value
means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets. 
 For these purposes, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger,
consolidation, purchase or acquisition of stock, or similar business transaction with the Company. 
 Notwithstanding the
foregoing provisions of this definition, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Section 409A. 
  

 -6- 

 (c) Disability. “Disability” will mean: 
 (i) Any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a
continuous period of not less than twelve (12) months that has resulted in Executive becoming eligible to receive benefits for a period of not less than three (3) months on account of a total disability under the Company’s long term
disability insurance policy; or 
 (ii) Any medically determinable physical or mental impairment that can be expected to
result in death or can be expected to last for a continuous period of not less than twelve (12) months that renders Executive incapable of engaging in any substantial gainful activity, as determined by the Company or by the Board, as the case
may be, in that entity’s sole discretion. 
 (d) Good Reason. “Good Reason” will mean Executive’s
termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence of one or more of the following, without Executive’s consent: 
 (i) A material reduction in Executive’s authority, duties, or responsibilities relative to Executive’s duties, position or
responsibilities in effect immediately prior to such reduction[; provided, however, that a reduction in duties, position or responsibilities solely by virtue of the Company being acquired and made part of a larger entity shall not constitute
“Good Reason”]; 
 (ii) A material reduction by the Company of Executive’s base salary in effect immediately
prior to such reduction; 
 (iii) A material change in the geographic location at which Executive must perform services (in
other words, the relocation of Executive to a facility that is more than fifty (50) miles from Executive’s current location). 
 Executive will not resign for Good Reason without first providing the Company with written notice within sixty (60) days of the event that Executive believes constitutes “Good Reason” specifically
identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the date of such notice. 
 (e) Section 409A Limit. “Section 409A Limit” will mean the lesser of two (2) times: (i) Executive’s
annualized compensation based upon the annual rate of pay paid to Executive during Executive’s taxable year preceding Executive’s taxable year of Executive’s termination of employment as determined under, and with such adjustments as
are set forth in, Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to
Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated. 
  

 -7- 

 6. Successors. 
 (a) The Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger,
consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner
and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” will include any successor to the Company’s business and/or
assets which executes and delivers the assumption agreement described in this Section 6(a) or which becomes bound by the terms of this Agreement by operation of law. 
 (b) Executive’s Successors. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of,
and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 
 7. Arbitration. 
 (a) The Company and Executive each agree that any and all disputes
arising out of the terms of this Agreement, Executive’s employment by the Company, Executive’s service as an officer or director of the Company, or Executive’s compensation and benefits, their interpretation and any of the matters
herein released, will be subject to binding arbitration under the arbitration rules set forth in California Code of Civil Procedure Sections 1280 through 1294.2, including Section 1281.8 (the “Act”), and pursuant to California law.
Disputes that the Company and Executive agree to arbitrate, and thereby agree to waive any right to a trial by jury, include any statutory claims under local, state, or federal law, including, but not limited to, claims under Title VII of the Civil
Rights Act of 1964, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Sarbanes-Oxley Act, the Worker Adjustment and Retraining Notification Act, the
California Fair Employment and Housing Act, the Family and Medical Leave Act, the California Family Rights Act, the California Labor Code, claims of harassment, discrimination, and wrongful termination, and any statutory or common law claims. The
Company and Executive further understand that this Agreement to arbitrate also applies to any disputes that the Company may have with Executive. 
 (b) Procedure. The Company and Executive agree that any arbitration will be administered by Judicial Arbitration & Mediation Services, Inc. (“JAMS”), pursuant to its Employment Arbitration
Rules & Procedures (the “JAMS Rules”). The Arbitrator will have the power to decide any motions brought by any party to the arbitration, including motions for summary judgment and/or adjudication, motions to dismiss and demurrers,
and motions for class certification, prior to any arbitration hearing. The Arbitrator will have the power to award any remedies available under applicable law, and the Arbitrator will award attorneys’ fees and costs to the prevailing party,
except as prohibited by law. The Company will pay for any administrative or hearing fees charged by the Arbitrator or JAMS except that Executive will pay any filing fees associated with any arbitration that Executive initiates, but only so much of
the filing fees as Executive would have instead paid had he or she filed a complaint in a court of law. The Arbitrator will administer and conduct any arbitration in accordance with California law, including the California Code of Civil Procedure,
and the Arbitrator will apply substantive and procedural California law to any dispute or claim, without reference to rules of conflict of law. To the extent that the JAMS Rules conflict with California law, California law will take precedence. The
decision of the Arbitrator will be in writing. Any arbitration under this Agreement will be conducted in Alameda County, California. 
  

 -8- 

 (c) Remedy. Except as provided by the Act and this Agreement, arbitration will be
the sole, exclusive, and final remedy for any dispute between Executive and the Company. Accordingly, except as provided for by the Act and this Agreement, neither Executive nor the Company will be permitted to pursue court action regarding claims
that are subject to arbitration. 
 (d) Administrative Relief. Executive understands that this Agreement does not
prohibit him or her from pursuing any administrative claim with a local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment, including, but not limited to, the Department
of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National Labor Relations Board, or the Workers’ Compensation Board. This Agreement does, however, preclude Executive from pursuing court action regarding any such
claim, except as permitted by law. 
 (e) Voluntary Nature of Agreement. Each of the Company and Executive acknowledges
and agrees that such party is executing this Agreement voluntarily and without any duress or undue influence by anyone. Executive further acknowledges and agrees that he or she has carefully read this Agreement and has asked any questions needed for
him or her to understand the terms, consequences, and binding effect of this Agreement and fully understands it, including that Executive is waiving his or her right to a jury trial. Finally, Executive agrees that he or she has been
provided an opportunity to seek the advice of an attorney of his or her choice before signing this Agreement. 
 8. Notice.

 (a) General. Notices and all other communications contemplated by this Agreement will be in writing and will be
deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices will be addressed to him or her at the home address
which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its President. 
 (b) Notice of Termination. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a
notice of termination to the other party hereto given in accordance with Section 8(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts
and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the giving of such notice). The failure by Executive to
include in the notice any fact or circumstance which contributes to a showing of Good Reason will not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.

  

 -9- 

 9. Miscellaneous Provisions. 
 (a) No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor
will any such payment be reduced by any earnings that Executive may receive from any other source. 
 (b) Other
Requirements. Executive’s receipt of any payments or benefits under Section 3 will be subject to Executive continuing to comply with the terms of any confidential information agreement executed by Executive in favor of the Company and
the provisions of this Agreement. 
 (c) Waiver. No provision of this Agreement will be modified, waived or discharged
unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or
provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time. 
 (d) Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of
this Agreement. 
 (e) Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and
supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof. No waiver, alteration, or
modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement. 
 (f) Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the
State of California (with the exception of its conflict of laws provisions). Any claims or legal actions by one party against the other arising out of the relationship between the parties contemplated herein (whether or not arising under this
Agreement) will be commenced or maintained in any state or federal court located in the jurisdiction where Executive resides, and Executive and the Company hereby submit to the jurisdiction and venue of any such court. 
 (g) Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity
or enforceability of any other provision hereof, which will remain in full force and effect. 
 (h) Withholding. All
payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes. 
 (i) Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. 
 [Signature Page to Follow] 
  

 -10- 

 IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its
duly authorized officer, as of the day and year set forth below. 
  

									
	COMPANY	 		 	THERMAGE, INC.
				
		 		 	By:	 	 
					
		 		 		 	Title:	 	 
					
		 		 		 	Date:	 	 
			
	EXECUTIVE	 		 	
				
		 		 	By:	 	 
					
		 		 		 	Title:	 	 
					
		 		 		 	Date:	 	 

  

 -11-Value Added Reseller Agreement

 Exhibit 10.1 
 CONFIDENTIAL TREATMENT REQUESTED 
 [*] Denotes information for which confidential treatment has been requested.
Confidential portions omitted have been filed separately with the Securities & Exchange Commission. 
  

			
	LSCA VALUE ADDED RESELLER PROGRAM AGREEMENT	  	AHA47
		  	Exhibit R200L

 AGREEMENT NO. AHA47 
 THIS LSCA VALUE ADDED RESELLER PROGRAM AGREEMENT (“Agreement”) is entered into as of June 1, 2008 (the “Effective Date”), by and between Agilent Technologies,
Inc. (“Agilent”), and O.I. Corporation, (“Reseller”). 
 “Estimated Volume” is the monetary amount
of eligible Products and related Support that Reseller plans to order during the term of this Agreement. “Product(s)” means any hardware or consumables sold or Software licensed under this Agreement. “Software”
means one or more computer programs and related documentation. “Specifications” means specific technical information about Products published by Agilent in effect on the date Agilent ships the order. “Support” means
any standard service provided by Agilent. “Custom Support” means Support adapted to meet Reseller requirements. 
 1. APPOINTMENT 

  

	 	a)	Subject to the terms in this Agreement, Agilent appoints Reseller as an authorized, non-exclusive, Value Added Reseller for the Products set forth in exhibit E305.

  

	 	b)	Agilent authorizes Reseller to provide marketing and support of Products to end-users; and to create, market, sell, lease and support solutions described in Section 3a ii)
below. 

 2. RELATIONSHIP 
 Reseller and Agilent are independent contractors for purposes of this Agreement and any representation made or agreements executed by Reseller will be Reseller’s sole responsibility. This Agreement does not establish a franchise, joint
venture or partnership, or create any relationship of employer and employee, or principal and agent between the parties. 
 3. RESELLER CONDITIONS 

  

	 	a)	Reseller represents that as a Value-Added Reseller: 

  

	 	i)	It is experienced in the use and operation of the Products to be purchased hereunder and will be primarily responsible for the marketing and support of the Products to end-users.
Reseller may request marketing assistance from Agilent. Agilent will only be obligated to provide such assistance as was specifically and mutually agreed upon by both parties. 

  

	 	ii)	Products purchased hereunder will be incorporated in a solution consisting of other hardware and/or software with services that add substantial value to Products and will be sold or
leased by Reseller to end-users other than Reseller’s corporate parent, division, or any subsidiary of corporate parent. 

  

	 	iii)	It will maintain support and warranty services for the added value portion of the solution, unless otherwise stated in exhibit E305. 

  

	 	b)	For purposes such as Product safety notification and Product recall, Reseller shall provide Agilent a monthly Point of Sales report including Agilent Sales Order Number, Customer
name and address, Product Number and Number of units sold. 

	 	c)	If Reseller’s end-users purchase Products from Agilent, Reseller will have no claim against Agilent for compensation. 

  

	 	d)	Reseller will qualify for discounts on add-on Agilent Products and upgrades to Products previously purchased if: (i) Reseller initially resold the Product being enhanced or
upgraded in accordance with this Agreement, and (ii) Reseller has provided and continues to provide ongoing support on the initial Product to its end-user. 

  

	 	e)	Reseller is responsible for complying with all training requirements designated by Agilent on each eligible Product it carries. 

  

	 	f)	By signing this Agreement, Reseller acknowledges it’s responsibility to comply with US Nuclear Regulatory Commission (NRC) and all local regulations in force for radioactive
sources and expressly agrees that it or it’s Customer shall obtain all appropriate licenses/permits in order to correctly import/export/transport Agilent Electron Capture Detectors (ECD) in the country of resale. Subject to the local laws,
Reseller will provide Agilent copies of their ECD licenses or other applicable information to enable Agilent to validate Reseller’s compliance with the license requirements. Reseller furthermore commits to remove or verify appropriate disposal
of all ECDs within their countries of resale. Agilent will not be responsible for tracking of the ECD to Customer. Agilent will accept and dispose of all ECDs manufactured by HP / Agilent. 

  

	 	g)	Agilent reserves the right, at its discretion and upon reasonable notice to Reseller to verify Reseller’s compliance with this Agreement. At Agilent’s request, Reseller
will provide Agilent with information to substantiate that Reseller has fulfilled its obligations under this Agreement. If Reseller fails to comply with the terms of this Agreement, Agilent reserves the right either to terminate or not to renew this
Agreement subject to Section 11b). 

 4. SALE AND DELIVERY 
  

	 	a)	All orders are subject to acceptance by Agilent. Product orders must reference this Agreement, be issued during the term of this Agreement, and specify delivery within six
(6) months from order date. 

  

	 	b)	The minimum stocking order/delivery to Reseller is $1,000. If this minimum order volume is not reached, Agilent will be entitled to a handling fee of $50. This shall not apply in
the case where the order is placed electronically. 

  

	 	c)	Reseller may cancel orders for Products (except custom Products) prior to shipment at no charge. Product returns will be subject to Agilent’s approval and return/refurbishment
charges. 

  

	 	d)	Title to hardware and consumables Products and acceptance of Products by Reseller will occur upon delivery. 

  

	 	e)	Unless otherwise indicated on the quotation, prices include shipping and handling charges in accordance with the applicable trade term. Prices exclude any sales, value added or
similar tax which will be payable by Reseller. 

  

	 	f)	Sales of Products to Reseller’s corporate parent, division or majority owned subsidiary are not eligible for discount. 

  

	 	g)	Agilent may, from time to time, offer Reseller marketing programs based on terms and conditions applicable to such programs. 

  

	 	h)	Payment is due thirty (30) days from Agilent’s invoice date. Agilent may change credit or payment terms at any time should Reseller’s financial condition or previous
payment record so warrant. Agilent may discontinue performance if Reseller fails to pay any sum due or to perform under this Agreement if, after ten (10) days written notice, the failure has not been cured. 

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 5. LICENSES 
  

	 	a)	Agilent grants Reseller a non-exclusive license to distribute and use, including for demonstration purposes, the Software and related materials supplied by Agilent in accordance
with the license terms included with the Software. Reseller agrees that it will pass through to end users Agilent’s license terms whenever Software is distributed to an end user. 

  

	 	b)	Except as authorized by Agilent in writing or as permitted by law, Reseller will not reverse engineer, reverse compile, or reverse assemble Software, modify or translate Software or
copy Software onto any public or distributed network. 

 6. PRODUCT MODIFICATIONS 
 Reseller will submit in writing to Agilent any proposed product modifications which might affect either the performance, safety or radiated emissions
certifications of Product. In the event Agilent believes such modifications may have an adverse effect, Agilent reserves the right to modify this Agreement to clarify the rights and obligations of Agilent and Reseller with respect to support,
marketing and technical specifications. 
 7. PRODUCT DEMONSTRATION AND DEVELOPMENT 
  

	 	a)	Reseller may purchase Products with demo discount defined in the exhibit E305 for the purposes of developing a new or testing an existing product which incorporates
Products along with Reseller hardware or software products, or demonstration of Products in combination with Reseller’s products at trade shows or customer training facilities. Such Products may not be resold for a minimum of eight
(8) months after delivery. 

  

	 	b)	Agilent may offer used Products updated to current technical specifications if allowed by local regulations. Products purchased under this Section are limited to the minimum
configuration(s) necessary to accomplish Reseller’s development, testing or demonstration objectives, unless add-ons, upgrades or additional Products are agreed to by Agilent in writing. 

  

	 	c)	No right, title or interest in each other’s products is granted or implied from the demo discount except as expressly stated. 

 8. TRADEMARKS 
  

	 	a)	Agilent may use Reseller’s trademark or logo for the purpose of fairly and accurately referring to Reseller on Agilent websites and training material that provides information
about Agilent’s channel partners. 

  

	 	b)	Reseller’s right to use any Agilent trademarks and/or service marks is specified in exhibit I5 in this Agreement. 

  

	 	c)	Reseller will not, without Agilent’s prior written consent, remove, alter or modify serial or identification numbers, labels, trademarks or other trade-identifying symbols from
Products sold or materials provided by Agilent under this Agreement. 

  

	 	d)	Agilent will have the sole and exclusive right in its sole discretion to bring legal actions for trademark infringement with respect to any of the Agilent trademarks and/or service
marks. Reseller will assist Agilent in such legal proceedings. Reseller will notify Agilent promptly of any trademark or patent infringements of which it has knowledge. 

 9. INTELLECTUAL PROPERTY CLAIMS 
  

	 	a)	Agilent will defend or settle any claim against Reseller, (or end users or third parties to whom Reseller is authorized by Agilent to resell or sublicense), that a Product infringes
an intellectual property right, provided Reseller promptly notifies Agilent in writing and provides control of the defense or settlement, and assistance to Agilent. 

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

	 	b)	In defending or settling an infringement claim under Section 9(a), Agilent will pay infringement claim defense costs, settlement amounts and court-awarded damages. If such a
claim appears likely, Agilent may, at its option, modify or replace the Product or procure any necessary license. If Agilent determines that none of these alternatives is reasonably available, Agilent will refund Reseller’s purchase price upon
return of the Product. 

  

	 	c)	Agilent has no obligation for any claim of infringement arising from Agilent’s compliance with, or use of, Reseller’s designs, specifications or instructions or technical
information; Product modifications by Reseller or a third party; Product use prohibited by Specifications or related application notes; or use of the Product with products not supplied by Agilent. 

 10. LIMITATION OF LIABILITY AND REMEDIES 
  

	 	a)	In no event will Agilent, its subcontractors or suppliers be liable for special, incidental, indirect or consequential damages (including downtime costs, loss of data, restoration
costs, lost profits, or cost of cover) regardless of whether such claims are based on contract, tort, warranty or any other legal theory, even if advised of the possibility of such damages. This exclusion is independent of any remedy set forth in
this Agreement. 

  

	 	b)	To the extent that limitation of liability is permitted by law, Agilent’s liability to Reseller is limited to US $1,000,000, except that Agilent’s obligation to make
warranty refunds defined in exhibit E305 is limited to the Product purchase price. 

  

	 	c)	The limitations set forth in Sections 10(a) and 10(b) above will not apply to infringement claims under Section 9, or to damages for bodily injury or death.

  

	 	d)	The remedies in this Agreement are Reseller’s sole and exclusive remedies. 

 11. TERM AND TERMINATION 
  

	 	a)	This Agreement will remain in effect for a period of twelve (12) months from the Effective Date. Prior to the expiration of the Agreement, the parties may agree to a renewal
term. Estimated Volumes and exhibits will be reviewed and revised as appropriate prior to any such renewal. 

  

	 	b)	This Agreement may be terminated immediately upon notice in writing by either party, for cause, unless the other party cures the breach within thirty (30) days of written
notice of such breach. 

  

	 	c)	This Agreement will terminate automatically if either party is subject to a voluntary or involuntary bankruptcy petition, becomes insolvent, is unable to pay its debts as they
become due, ceases to do business as a going concern, makes an offer or assignment or compromise for the benefit of creditors, or there is a substantial cessation of its regular course of business, or a receiver or trustee is appointed for such
party’s assets. 

  

	 	d)	Provisions herein which by their nature extend beyond the termination or expiration of this Agreement will remain in effect until fulfilled. 

 12. CONFIDENTIALITY 
  

	 	a)	In the event that confidential information is exchanged, each party will protect and safeguard the confidential information of the other in the same manner in which it protects its
own equivalent confidential, and trade secret information, but in no event less than a reasonable degree of care. The party claiming the benefit of this provision must furnish such information in writing and mark such information as
“Confidential” or if such information is provided orally, then the transmitting party (“Discloser”) will designate such information as being confidential at the time of disclosure and confirm in writing to the

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

	 	 
receiving party (“Recipient”) that it is confidential within thirty (30) days of its communication. Such information will remain confidential
for three (3) years after the date of written disclosure. 

  

	 	b)	This Section imposes no obligation upon a Recipient with respect to confidential information that (a) was in the Recipient’s possession before the disclosure; (b) is
or becomes a matter of public knowledge through no fault of the Recipient; (c) is rightfully received by the Recipient from a third party without a duty of confidentiality; (d) is disclosed by the Discloser to a third party without a duty
of confidentiality on the third party; (e) is independently developed by the Recipient; (f) is disclosed under operation of law; or (g) is disclosed by the Recipient with the Discloser’s prior written approval.

 13. GENERAL 
  

	 	a)	All notices that are required under this Agreement must be in writing and will be considered given as of twenty-four (24) hours after sending by electronic means, facsimile
transmission, overnight courier, or hand delivery, or as of five (5) days of certified mailing and appropriately addressed as follows: 

  

							
		 	Reseller:	  	Agilent:	  	
				
		 	O.I. Corporation	  	Agilent Technologies, Inc.	  	
				
		 	151 Graham Road	  	2850 Centerville Road	  	
				
		 	College Station, TX 77845	  	Wilmington, DE 19808	  	
				
		 	Facsimile: 979-690-0440	  	Facsimile: 302-993-5788	  	

  

	 	b)	Agilent may assign or transfer this Agreement without consent in connection with a merger, reorganization, change of control or ownership, or transfer or sale of assets or product
lines. Reseller may not assume this Agreement in connection with any bankruptcy proceedings without Agilent’s written consent. 

  

	 	c)	Agilent will store and use any of the Reseller’s personal data in accordance with Agilent’s Privacy Statement, available at www.agilent.com/go/privacy. Agilent will
not sell, rent or lease Reseller’s personal data to others. 

  

	 	d)	Terms for service are available at http://www.agilent.com/go/service_terms, upon request or as indicated on the quotation. 

  

	 	e)	Reseller who exports, re-exports, transfers or imports Products, technology or technical data purchased hereunder, assumes responsibility for complying with applicable U.S. and
other laws and regulations and for obtaining any required export and import authorizations. Agilent may terminate this Agreement immediately if Reseller is in violation of any applicable laws or regulations. 

  

	 	f)	Disputes arising in connection with this Agreement will be governed by the laws of the State of California, and the courts of that state will have jurisdiction, except
that Agilent may, at its option, bring suit for collection in the country where Reseller is located. 

  

	 	g)	Neither party’s failure to exercise any of its rights under this Agreement will be deemed a waiver or a forfeiture of those rights. 

  

	 	h)	Reseller will conduct all its activities relating to its business with Agilent in accordance with the highest standards of ethics and fairness as well as compliance with applicable
law. Agilent may immediately terminate this Agreement if Reseller fails to do so. 

  

	 	i)	To the extent that any provision of this Agreement is determined to be illegal or unenforceable in a particular country, the remainder of the Agreement will remain in full force and
effect. 

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

	 	j)	The United Nations Convention on Contracts for the International Sale of Goods will not apply to this Agreement or to transactions processed under this Agreement.

  

	 	k)	Any Products loaned during the term of this Agreement will be subject to Agilent’s standard Equipment Loan Agreement. 

  

	 	l)	Products are not specifically designed, manufactured or intended for sale as parts, components or assemblies for the planning, construction, maintenance or direct operation of a
nuclear facility. Agilent shall not be liable for any damages resulting from such usage. 

  

	 	m)	This Agreement constitutes the entire understanding between Agilent and Reseller, and supersedes any previous communications, representations or agreements between the parties,
whether oral or written, regarding transactions hereunder. Reseller’s additional or different terms and conditions will not apply. This Agreement may not be changed except by an amendment signed by an authorized representative of each party.

 14. EXHIBITS 
 The
following exhibits are attached hereto and are incorporated into this Agreement. 
  

	 	a)	Agilent Channel Partner Insignia Exhibit (I5) 

  

	 	b)	LSCA Value Added Reseller Compensation Exhibit (E305) 

  

	 	c)	Value Added Resellers Business Plan LSCA Products (E306) - reserved 

 In the event of any conflict between the terms and conditions of the exhibits mentioned above and the terms and conditions set forth in this Agreement, the latter will govern. 
 IN WITNESS WHEREOF, The parties have duly executed this Agreement effective as of the date indicated above: 
  

							
	 AGREED TO:
	 	AGREED TO:
				
	 Reseller:
	 	O.I. Corporation	 	Agilent:	 	Agilent Technologies, Inc.
				
		 	 /s/ J. Bruce Lancaster
	 		 	 /s/ Rose Douglas

		 	Authorized Representative Signature	 		 	Authorized Representative Signature
	Name:	 	J. Bruce Lancaster	 	Name:	 	Rose Douglas
	Title:	 	CEO/CFO	 	Title:	 	Contracts Specialist
				
	Address:	 	151 Graham Road	 	Address:	 	2850 Centerville Road
		 	College Station, TX 77845	 		 	Wilmington, DE 19808
				
	Date:	 	May 28, 2008	 	Date:	 	May 29, 2008

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

			
	 AGILENT CHANNEL PARTNER INSIGNIA EXHIBIT
	  	Exhibit 15

 WHEREAS, Agilent Technologies, Inc. (“Agilent”) is the owner of all right, title and interest in and to
the Agilent trademarks/service marks referenced in this Exhibit I5. 
 WHEREAS, O.I. Corporation “Participant”) wishes to use the
Insignia in connection with the Program outlined in the Referenced Agreement. 
 Therefore, the purpose of this Exhibit is to provide eligible participants
in the Agilent Channel Partner Program with a right to use an insignia that identifies them as such, under conditions that properly protect the insignia. 
 1. DEFINITIONS 
  

	 	a.	“Referenced Agreement” means Agreement No.AHA47 effective June 1, 2008 between Agilent and Participant, of which this Exhibit is a part.

  

	 	b.	“Program” means the Agilent program under which Participant has been admitted as a Channel Partner by written notice. 

  

	 	c.	“Authorized Products” means Agilent products identified and authorized in the Referenced Agreement. 

  

	 	d.	“Authorized Services” means the services Participant is authorized by the Referenced Agreement to provide with respect to the Authorized Products (including as applicable
materials used in the advertising, promotion and sale of such products or services). 

  

	 	e.	“Insignia” means the insignia shown below (which Agilent may amend from time to time): 

 

 
  

	 	f.	“Agilent Mark” means any trademark, trade name, logo or insignia, including the Insignia, owned by Agilent Technologies, Inc. (“Agilent”) or any of its
subsidiaries (collectively, with their parent, the “Agilent Companies”). 

 2. INSIGNIA OWNERSHIP 
 Participant acknowledges that the Insignia is a trademark of Agilent and that it will remain the sole property of Agilent. Participant’s right to use
the Insignia arises solely by virtue of this Exhibit, and Participant will acquire no rights in the Insignia through use. Participant agrees not to attack or challenge the validity of the Insignia as a trademark, Agilent’s ownership thereof, or
Agilent’s right to control the use of the Insignia. Participant agrees that any use it makes of the Insignia will inure to the benefit of Agilent. 
 3. AUTHORIZATION 
 Participant is authorized to use the Insignia (the “Authorization”) solely in connection with
the Authorized Services, and pursuant to and in compliance with the Referenced Agreement. Participant will not use the Insignia other than in connection with the Authorized Services. Participant will comply with all provisions in this Exhibit and
the Referenced Agreement as well as the Authorized Channel Partner Insignia Standards published at http://www.agilent.com/secure/agilentbrand/ (Username: [*] Password: [*]), and all rules, 
  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 
standards or guidelines promulgated from time to time by Agilent for the display and use of the Insignia. Participant will at all times use the Insignia in
good taste and will refrain from using it in a manner that would bring the Agilent Companies into disrepute. Participant will not use the Insignia in a manner that is likely to confuse consumers as to the nature or extent of its relationship with
the Agilent Companies. This Exhibit does not authorize Participant to use any other Agilent Mark in connection with the Authorized Services. Participant will promptly report to Agilent any unauthorized use of Agilent Marks that comes to
Participant’s attention. Participant will not incorporate the word AGILENT into its domain or business names. Any change or addition to the scope or duration of this Authorization must be in writing and must be signed by an authorized
representative of Agilent. 
 4. QUALITY STANDARDS 
 Participant agrees to maintain at least the same level of quality for the Authorized Services as it maintained when the Participant qualified for the Program, and to comply with all standards set by the Agilent
Companies from time to time for inclusion in the program (taken together, the “Quality Standards”). Participant understands that Agilent will from time to time evaluate the Authorized Services for compliance with the Quality Standards,
including surveying Participant’s customers, and Participant agrees to cooperate with Agilent in any such evaluation. Any time that, in Agilent’s sole judgment and absolute discretion, the Authorized Services fail to meet the Quality
Standards, Agilent may immediately terminate the Authorization. 
 5. TERMINATION 
 Agilent may terminate or suspend the foregoing Authorization (i) at will upon thirty (30) days prior written notice in the event Agilent
suspends or changes the Program or (ii) immediately upon written notice to Participant if Participant fails to comply with any of the provisions of this Exhibit or any of the rules or standards promulgated by Agilent for the use of the
Insignia. This Authorization will automatically terminate upon the termination of the Referenced Agreement. Upon any termination of the Authorization, Participant will immediately cease use of the Insignia. Without limiting the foregoing,
Participant agrees to remove the Insignia from any and all products and materials in Participant’s possession or control, and to replace any products or materials that bear the Insignia that are still in the hands of any distributors or other
resellers with products and materials that do not bear the Insignia. Participant agrees that any unauthorized use of the Insignia will cause irreparable harm to Agilent, for which damages would not be an adequate remedy, and agrees not to contest
the entry of an immediate injunction should Participant engage in any such unauthorized use. 
 6. APPROVALS 
 Participant will, upon request by an Agilent Company, submit to the requesting party for its prior approval any and all proposed uses for the Insignia.
Any failure by the Agilent Company to object to a particular use or omission by Participant will not be construed as a waiver of the right to object to or require changes in such use or omission in the future, nor will it be construed as an approval
of such use or omission. 
 7. REGISTRATIONS 
 Participant will cooperate with Agilent in making or facilitating any governmental registrations or submissions that are necessary to protect the Insignia and Agilent’s ownership thereof, including, but not limited to, registration of
Participant as a Registered User of the Insignia. Upon termination of this Exhibit, Participant will cooperate with Agilent in the revocation of any such registration. 
 8. LEGAL RELATIONSHIP 
 Participant’s relationship with the Agilent Companies will be that of an
independent contractor. Neither party will have, nor represent that it has, any power, right or authority to bind the other party, or to assume or create any obligation or responsibility, express or 
  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 
implied on behalf of the other party. Nothing stated in this Exhibit will be construed as creating a legal partnership between Participant and the Agilent
Companies, or as creating the relationship of employer and employee, master and servant or principal and agent between or among the parties. 
 9.
COMMUNICATIONS WITH THIRD PARTIES 
 Participant understands that the term “partner” is often used to promote arms-length
relationships between a hardware vendor and non- affiliated business entities such as VARs, OEMs and software suppliers. Participant will not suggest that the use of the term “partner” as part of the Insignia implies any actual legal
partnership between Participant and Agilent or the Agilent Companies. Participant will not hold itself out to third parties as being in a legal partnership, sharing profits or losses, or sharing management responsibility with any Agilent Company.

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 LSCA VALUE ADDED RESELLER COMPENSATION EXHIBIT AHA47 
 Exhibit E305 
 DISCOUNT SUMMARY TABLE  
  

									
	 	  	COLUMN
I	  	COLUMN
II	  	COLUMN
III	  	COLUMN
IV
	 Volume Discount (Section 1)
	  	[*]	  	[*]	  	[*]	  	[*]
	 Volume Performance Discount (Section 2)
	  	[*]	  	[*]	  	[*]	  	[*]
	 TOTAL DISCOUNT PERCENTAGE
	  	[*]	  	[*]	  	[*]	  	[*]

 1. VOLUME BASED DISCOUNT 
 Eligible Products, including applicable standard options, will receive discounts in accordance with the following “Discount Percentage Schedule” at the Estimated Volume level established under this Exhibit.
The discounts granted under this Exhibit are in lieu of and not in addition to any other discounts that might be available from Agilent with the exception of certain special promotions that may be offered from time to time. 
 DISCOUNT PERCENTAGE SCHEDULE 
  

													
	WORLDWIDE
US DOLLAR NET	  	I	  	II	  	III	  	IV
	100,000	  	-	  	499,999	  	[*]	  	[*]	  	[*]	  	[*]
	500,000	  	-	  	999,999	  	[*]	  	[*]	  	[*]	  	[*]
	1,000,000	  	-	  	1,999,999	  	[*]	  	[*]	  	[*]	  	[*]
	2,000,000	  	-	  	3,999,999	  	[*]	  	[*]	  	[*]	  	[*]
	4,000,000	  	-	  	6,499,999	  	[*]	  	[*]	  	[*]	  	[*]
	6,500,000	  	-	  	UP	  	[*]	  	[*]	  	[*]	  	[*]

 PRODUCTS SUBJECT TO DISCOUNT 
 Reseller is appointed for the following Products as defined by the solutions in the business plan: 
 GC and GC/MS hardware
and software products to be used with the OI Analytical purge and trap and PID/ELCD products. OI Analytical to provide solutions for the environmental market. 
  

					
	COLUMN I	  	ALL PRODUCTS FROM PRODUCT LINES	  	 AA   Proprietary Supplies
 58     Analytical Supplies
 BC   LC Columns
 JW   GC Columns

			
	COLUMN II	  	SELECTED PRODUCTS FROM PRODUCT LINES	  	 AZ* Gas Chromatography systems and related Products
 CA* Emerging Markets Measurement Solutions
 BZ* Gas Chromatography/ Mass Spectroscopy Systems and Related Products

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

					
	COLUMN III	  	SELECTED PRODUCTS FROM PRODUCT LINES	  	 29*  Liquid Chromatography and related Products
 MA  Spectroscopy and Particle Analysis
 89*  LC Mass Spectrometers
 LI     Laboratory Informatics

			
	COLUMN IV	  	PRODUCTS FROM PRODUCT LINES	  	 8P    Replacement Parts

  
  

	*	Discounts also include all ChemStations associated with these Products 

 Notwithstanding the foregoing, Agilent reserves the right to determine which Products are eligible for discount. 
 PL29 PRODUCTS NOT ELIGIBLE
FOR DISCOUNT 
  

			
	G1411A	  	Oracle client license
		
	G4240A	  	HPLC-Chip MS Interface for use with Agilent MS

 2. VOLUME PERFORMANCE DISCOUNT 
 Reseller will receive a Volume Performance Discount of [*] percent ([*]%) on all orders placed during the following six (6) month period for Products in Column II and III, if Reseller’s total net purchases
of Agilent Products under this Agreement for the prior six (6) months equal or exceed one hundred percent (100%) of volume target specified in Table 1 below. 
 For new Resellers the Volume Performance Discount will commence only after the initial seven (7) months of the Agreement period. Reseller will not be eligible to receive Volume Performance discount
unless a business plan has been agreed to between Reseller and Agilent. Should this Agreement be renewed, this section is also applicable during the first seven (7) months of the renewal period. 
 TABLE 1 
 NET SALES VOLUME TARGET*

  

					
	 January 1 through May
 31– Agreement period
	 	 June 1 through December
 31– Agreement period
	 	 Agreement period –
 Annual Volume Target

	N/A	 	[*]	 	[*]

  

	*	If Reseller’s initial agreement period is less than 12 months the volume estimate will be prorated on the basis of 12 months. 

 3. DEMO DISCOUNT 
 Products purchased for demonstration and
development purposes receive an additional discount of [*] percent ([*]%), subject to Section 7 in R200L. 
  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 4. WARRANTY 
 The
following warranty terms shall apply: 
  

	a)	Reseller will receive an on-site warranty for Products beginning upon Reseller’s acceptance and ending either ninety (90) days thereafter or on the date that Reseller
ships the Product(s) to the end-user, whichever occurs first. The end user warranty period for Products begins ninety (90) days after Reseller’s acceptance or the date the Product is received by the end-user, whichever occurs first.
 

  

	b)	Agilent reserves the right to change the warranty. Such changes will affect only new orders. 

  

	c)	Reseller may provide more extensive warranties to end-users for certain Products only to the extent it receives Agilent’s prior approval and provided further that Reseller
indemnifies Agilent against damages, liability or claims arising from Reseller’s breach of such warranties or associated warranty service. 

  

	d)	End-users must provide proof of purchase to be eligible for Agilent warranty service. 

 WARRANTY TO END USERS 
  

	a)	Product warranty terms are provided with the Product, on quotations, upon request or at http://www.agilent.com/go/warranty_terms. Each Product receives a global warranty
which includes the standard warranty for the country of purchase. 

  

	b)	Agilent warrants the Agilent hardware and consumables Products against defects in materials and workmanship and that the Product will conform to Specifications. Agilent warrants
that Agilent owned standard Software substantially conforms to Specifications. 

  

	c)	If Agilent receives notice of defects or non-conformance during the warranty period, Agilent will, at its option, repair or replace the affected Product. Reseller or end user will
pay expenses for return of such Product(s). Agilent will pay expenses for shipment of repaired or replacement Product(s). 

  

	d)	THE ABOVE WARRANTIES ARE EXCLUSIVE, AND NO OTHER WARRANTY, WHETHER WRITTEN OR ORAL, IS EXPRESSED OR IMPLIED. AGILENT SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES OF MERCHANTABILITY
AND FITNESS FOR A PARTICULAR PURPOSE. 

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 Exhibit E306 
 S1 
 Value Added Resellers Business Plan LSCA Products 
 Company Name: OI Analytical 
 Agreement Number: TBD 
 1. Volume Estimation by Product Line 
 Product Lines 
  

															
	 	  	Q1	  	Q2	  	Q3	  	Q4	  	1H	  	2H	  	CY
	 PL AZ – GC Products
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 Pl CA – Emerging Markets Measurement Solutions
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL BZ – GC/MS Products
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL 29 – LC Products
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL MA – Spectroscopy and Particle Analysis
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL 89 – LC Mass Spectrometers
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL LI – Laboratory Informatics
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PLs AA, 58, JW and BC – Consumables and Columns
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 PL 8P – Replacement Parts
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]
	 TOTAL
	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]	  	[*]

 Note: The above Total amounts will serve as the basis for the calculation of the Volume Performance
Discount. 
 2. Activities Planned to Qualify for Functional Discounts 
  

	 	A.	Value added solutions 

 Please list all the
proposed value added solutions based on Agilent Products you will offer (add lines as appropriate). These solutions will be the only Value Added Solutions for which discounts are available under this agreement. New solutions introduced during the
Agreement period require Agilent approval to become eligible for the VAR discounts. 
  

			
	 Solution 1:
	    	
		
	 Description:
	    	Environmental system including the Agilent GC/MS and the OI Eclipse P&T System.
		
	 Agilent Products content:
	    	7890, 5975C, and software

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

			
	 Solution 2:
	  	
		
	 Description:
	  	GC system including the Agilent GC and OI ELCD/PID detectors
		
	 Agilent Products content:
	  	7890 and GC or GC/MS software

 3. Sales and Service Coverage Release point for all regions is College Station, TX

 Please define geographic area with abilities to provide on-site sales and service activities on regular basis under this Agreement. The
geographic areas are subject to Agilent’s prior written approval. 
  

					
	 Countries/Region
	 	 Number of Sales Personnel
	 	 Number of Service Personnel

	 North America and Latin America/AFO
	 		 	
		 	 	 	 
	 Europe/EMEA
	 		 	
		 	 	 	 
	 Asia/APFO
	 		 	
		 	 	 	 

  

			
	 Demo capabilities:
	  	
		
	Please provide details of demo facility planned demo inventory and demo specialists.	  	Demo facility includes a new 7890/5975C with capillary flow technology connected to an Eclipse P&T. There are other Agilent GC and GC/MS products in the production and R&D labs

 3. Customer Database Management 
 Please indicate your willingness to share endues profiles with Agilent for improving effectiveness of marketing. 
  

							
		 	Yes	  		 	No
	 Do you maintain customer profile database
	 	 	  		 	 
	 Are you willing to share customer profiles with Agilent
	 	 	  		 	 

 4. Support Plan 
 The following services will be available to customers: 
  

									
		 		 	Yes	  		 	No
	 Method development
	 		 	 	  		 	 
	 Application assistance and troubleshooting
	 		 	 	  		 	 
	 HW support
	 		 	 	  		 	 
	 HW support online
	 		 	 	  		 	 
	 SW support
	 		 	 	  		 	 
	 SW support online
	 		 	 	  		 	 

									
	 Other:
	 	 	 	

 5. Marketing Plan 
 Indicate all the activities you plan to run independently from Agilent to promote your company and the products and marketing activities you will run
for Agilent and with Agilent. 
 Customer seminars: 
 Telemarketing Activities planned: 
  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission. 

 Promotional Activities: 
 Participation with Agilent:    Would you like to participate in Agilent Sales activities? 
                 Y/N 
 Which Agilent Sales
Activities do you feel are most effective: 
  

					
	Reseller Signature:	 	 /s/ J. Bruce Lancaster
	  	Date: 5/28/08
			
	Agilent Signature:	 	 /s/ Rose Douglas
	  	Date: 5/29/08

  

	[*]	Denotes information for which confidential treatment has been requested. Confidential portions omitted have been filed separately with the Securities & Exchange
Commission.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]